Sblendorio Glenn

Sblendorio Glenn is listed in filings as Director at AMICUS THERAPEUTICS INC. This profile follows SEC Form 4 activity through Apr 27, 2026, including 15 public disclosures. Recent filings connect the profile to AMICUS THERAPEUTICS INC (FOLD) and Mineralys Therapeutics, Inc. (MLYS). The current snapshot covers public activity from Feb 24, 2025 to Apr 27, 2026. Reported amounts are shown as $2.1M to $436.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.